FDA Clearance Tracker · P220026
Symplicity Spyral Renal Denervation System
Last checked: Nov 19, 2026Latest source record: Nov 17, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Nov 17, 2023
Approved
Time to decision
374 days
Received Nov 8, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P220026
- Device name
- Symplicity Spyral Renal Denervation System
- Applicant
- Medtronic, Inc.
- Applicant location
- Santa Rosa, CA
- Received
- Nov 8, 2022
- Decided
- Nov 17, 2023
- Decision
- Approved
- Supplements
- 17 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Ablation catheter, renal denervation (QYI)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
The Symplicity Spyral Multi-Electrode Renal Denervation Catheter and the Symplicity G3 RF Generator are indicated to reduce blood pressure as an adjunctive treatment in patients with hypertension in whom lifestyle modifications and antihypertensive medications do not adequately control blood pressure.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QYI. The earliest in FDA's data is P220023, decided Nov 7, 2023.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
K262913 · Decided Sep 17, 2026 · 29 days after receipt
Device type: Stents, Drains And Dilators For The Biliary Ducts (FGE) · GI, Urology & Nephrology
K262735 · Decided Aug 28, 2026 · 28 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.